drugset / Trial / NCT04554524
Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This is an investigational, single arm study.
Timeline
- Start
- 2020-08-27
- Primary completion
- 2024-07-30
- Completion
- 2024-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbo-paclitaxel | Unknown | — | — |
| Subject | Paclitaxel | Small molecule | — | — |
| Subject | Pembrolizumab | Monoclonal antibody | — | — |